Literature DB >> 29198944

The Study of Clear Cell Renal Cell Carcinoma with MR Diffusion Kurtosis Tensor Imaging and Its Histopathologic Correlation.

Guangyu Wu1, Zizhou Zhao1, Qiuying Yao1, Wen Kong2, Jianrong Xu3, Jin Zhang4, Guiqin Liu5, Yongming Dai6.   

Abstract

RATIONALE AND
OBJECTIVES: The objective of this study was to compare the performance of diffusion kurtosis tensor imaging and diffusion-weighted imaging in the characterization of clear cell renal cell carcinoma (ccRCC) and their correlations with tumor histopathology.
MATERIALS AND METHODS: Ninety-one patients diagnosed with ccRCC who underwent diffusion kurtosis tensor imaging were included in this study. Fractional anisotropy, mean diffusivity, radial diffusivity, axial diffusivity, mean kurtosis (MK), radial kurtosis (Krad), and axial kurtosis (Kax) data were produced. A nuclear grade of 1-4 (G1-4) was assigned for each case based on the Fuhrman grading system, whereas tumor histopathology was characterized by the nuclear-to-cytoplasm ratio, the cell nuclei count, and the cell volume fraction.
RESULTS: All of the metric values except for Kax and fractional anisotropy could be used to discriminate G1 vs G3, G1 vs G4, G2 vs G3, and G2 vs G4, whereas MK and Kax could be used to discriminate G3 vs G4 (P <0.05). Moreover, the MK and Krad values exhibited better performance in differentiating G2 from G3 (P < 0.04 compared to the other metrics). The nuclear-to-cytoplasm ratio was positively correlated with the MK, Krad, and Kax values (P <0.001) and negatively correlated with the mean diffusivity, radial diffusivity, and axial diffusivity values (P <0.001), whereas the cell volume fraction and the cell nuclei count did not correlate with any metric examined.
CONCLUSION: The kurtosis metrics were superior to the diffusion metrics in grading ccRCC.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell Renal cell carcinoma; diffusion kurtosis tensor imaging; histopathologic correlation

Mesh:

Year:  2017        PMID: 29198944     DOI: 10.1016/j.acra.2017.10.016

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  7 in total

1.  Usefulness of computed tomography textural analysis in renal cell carcinoma nuclear grading.

Authors:  Israa Alnazer; Omar Falou; Pascal Bourdon; Thierry Urruty; Rémy Guillevin; Mohamad Khalil; Ahmad Shahin; Christine Fernandez-Maloigne
Journal:  J Med Imaging (Bellingham)       Date:  2022-09-13

2.  Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.

Authors:  Fang Wang; Hai-Ge Chen; Rui-Yun Zhang; Di Jin; Shuai-Shuai Xu; Guang-Yu Wu; Jian-Rong Xu
Journal:  Eur Radiol       Date:  2019-01-21       Impact factor: 5.315

3.  Renal cell carcinoma: preoperative evaluate the grade of histological malignancy using volumetric histogram analysis derived from magnetic resonance diffusion kurtosis imaging.

Authors:  Ke Wang; Jingyun Cheng; Yan Wang; Guangyao Wu
Journal:  Quant Imaging Med Surg       Date:  2019-04

4.  Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades.

Authors:  Jie Zhu; Xiaojie Luo; Jiayin Gao; Saying Li; Chunmei Li; Min Chen
Journal:  Cancer Imaging       Date:  2021-03-16       Impact factor: 3.909

5.  Diffusion kurtosis imaging features of renal cell carcinoma: a preliminary study.

Authors:  Qingqiang Zhu; Qing Xu; Weiqiang Dou; Wenrong Zhu; Jingtao Wu; Wenxin Chen; Jing Ye
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

6.  CT-based transformer model for non-invasively predicting the Fuhrman nuclear grade of clear cell renal cell carcinoma.

Authors:  Meiyi Yang; Xiaopeng He; Lifeng Xu; Minghui Liu; Jiali Deng; Xuan Cheng; Yi Wei; Qian Li; Shang Wan; Feng Zhang; Lei Wu; Xiaomin Wang; Bin Song; Ming Liu
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

Review 7.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.